Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Rheumatology (Oxford, England)|December 14, 2019
The use of real-world data to address questions of patient safetyMark Yates, Katie Bechman, James Galloway
Pharmacological Research|August 12, 2019
The new entries in the therapeutic armamentarium: The small molecule JAK inhibitorsKatie Bechman, Mark Yates, James B Galloway
Future Healthcare Journal|February 3, 2026
Rheumatology 2050: How our specialty is changingMariam Omar, Katie Bechman, Mark Russell, et al.
Seminars in Arthritis and Rheumatism|May 16, 2017
A cohort study reveals myocarditis to be a rare and life-threatening presentation of large vessel vasculitisKatie Bechman, Deepa Gopalan, Petros Nihoyannopoulos, et al.
Rheumatology (Oxford, England)|May 5, 2021
The safety of JAK-1 inhibitorsBenjamin Clarke, Mark Yates, Maryam Adas, et al.
BMC Infectious Diseases|December 7, 2017
Meningococcal arthritis and myopericarditis: a case reportLloyd Steele, Katie Bechman, Eoghan De Barra, et al.
Rheumatology (Oxford, England)|July 23, 2019
Centre effects and case-mix in early rheumatoid arthritis observational cohorts: a narrative reviewMark Yates, Katie Bechman, Sam Norton, et al.
Rheumatology (Oxford, England)|October 3, 2017
A review of the musculoskeletal manifestations of sarcoidosisKatie Bechman, Dimitrios Christidis, Sarah Walsh, et al.
The Journal of Rheumatology|May 3, 2019
Placebo Response in Rheumatoid Arthritis Clinical TrialsKatie Bechman, Mark Yates, Sam Norton, et al.
The Journal of Rheumatology|March 17, 2018
A Systematic Review and Metaanalysis of Antirheumatic Drugs and Vaccine Immunogenicity in Rheumatoid ArthritisSujith Subesinghe, Katie Bechman, Andrew I Rutherford, et al.
Pageof 7